Trial Profile
RC11C3, Pilot Placebo-Controlled Evaluation of Pregabalin as a Means to Prevent the Paclitaxel-Associated Acute Pain Syndrome
Status:
Active, no longer recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 26 Jul 2016
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary)
- Indications Acute pain
- Focus Pharmacokinetics; Therapeutic Use
- Sponsors Mayo Clinic
- 26 Jul 2016 New trial record